The province reported 2 deaths, 131 new cases of COVID-19 Thursday along with 102 recoveries.
There are 100 people in hospital, including 23 people in intensive care.
The two new deaths reported are in the 80+ age group, both from the North West zone.
The Saskatoon is reporting 34 new cases, Regina is reporting 21 new cases, the North West Zone is reporting 14 new cases, the South Central Zone is reporting 12 new cases, the South East Zone is reporting 11 new cases, the Far North East Zone is reporting 11 cases, the North Central Zone is reporting seven new cases, the North East Zone is reporting seven new cases, the Far North West Zone is reporting five new cases, the Central East Zone is reporting three new cases, and the Central West Zone is reporting two new cases.
1,314 cases are considered active in the province and 14 of the active cases are located in the Central West Zone.
As of Thursday, all individuals 65 years of age and older, or who had their first dose on or before March 22, can receive their second dose of the COVID-19 vaccine.
An additional 14,579 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 754,830. Over 100,000 Saskatchewan residents have now been fully vaccinated.
The 14,579 doses of COVID-19 vaccine reported today were administered to residents living in the following zones: Far North West, 156; Far North Central, 14; Far North East, 228; North West, 686; North Central, 1,067; North East, 490; Saskatoon, 4,909; Central West, 519; Central East, 1,003; Regina, 3,175; South West, 558; South Central, 497; and South East, 1,024. There were 253 doses administered with zone of residence pending.
Seventy-seven per cent of those over the age of 40 have received their first dose. Seventy-two per cent of those 30+ have received their first dose. Sixty-six per cent of those 18+ have received their first dose, while 63 per cent of those 12+ have also received their first dose.
Clinics offering AstraZeneca as a second dose will be announced this week. You are not required to receive AstraZeneca as a second dose when you are eligible, as you may receive Pfizer or Moderna if that is your preference.